NEW YORK, June 6, 2013 /PRNewswire/ --
New milestone in expanding cooperation with the leading Chinese medical publisher
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today signed a strategic collaboration agreement with People's Medical Publishing House (PMPH), China. The announcement expands on Elsevier's current publishing collaboration with the largest Chinese medical publisher in China.
Elsevier's collaboration with PMPH goes back to the 1990s. Since then PMPH has translated and published hundreds of Elsevier's book titles in health sciences. Under the new agreement, Elsevier and PMPH will deepen and expand their collaboration, not only translating English book titles into Chinese and vice versa, but now also facilitating international collaboration in authoring books and developing information products, as well as enabling distribution of these books and products to health professionals globally."It is part of our global strategy to continue to work with Elsevier," said Mr. Chen Xianyi, Chairman and President of PMPH. "With abundant resources from China's top medical universities, research institutions and hospitals, PMPH has great relationships in medical publishing. Our collaboration with Elsevier will improve our practices in digital publishing and diversification, and facilitate our process of transiting from a domestic publishing company to an international publishing group." "At Elsevier, we are committed to deliver world-class medical content and user-friendly databases to our customers around the world," said Gerrit Bos, Managing Director of Elsevier Health Sciences APAC. "Our strategic collaboration agreement with PMPH is a great step in providing access to top class medical resources for more clinicians, students and experts in medical professions in China." About People's Medical Publishing House People's Medical Publishing House Co., Ltd (PMPH) is the leading medical publisher in China. It produces books, journals and e-products including medical textbooks, clinical references, and patient education books both in western medicine and Traditional Chinese Medicine (TCM). PMPH publishes 3000 new titles and new editions annually and has prestigious local and international author teams. PMPH is headquartered in Beijing and employs more than 1000 people in and outside China. The company has 10 wholly-owned subsidiaries, including PMPH- USA, the Radegast Lakeview Hotel and Conference Center in Beijing, the PMPH Printing House, and the Beijing International Exhibition Company. About Elsevier Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively. A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL. Media contact Rose Wang Elsevier, APAC +86-10-8520-8866 email@example.com SOURCE Elsevier
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts